未來世界金融(00572.HK)下屬熔噴不織布生產線預計4月投產
格隆匯3月25日丨未來世界金融(00572.HK)發佈公告,面對當前新型冠狀病毒COVID-19疫情爆發、疫情在全球各地蔓延及口罩產品持續短缺局面,集團現已展開口罩生產業務,務求在短時間內為市場提供符合相關認證標準的口罩。
公告表示,在生產口罩中熔噴不織布是關鍵材料,是口罩核心,所以熔噴不織布更為短缺,而且熔噴不織布價格不斷攀升,集團務求為口罩生產提供數量及質量均有保證的原材料供應及保持價格優勢,公司一間全資附屬公司現已訂購熔噴生產線生產熔噴不織布,該附屬公司將具有卓越的熔噴技術及穩定性高製程,預期熔噴不織布生產將於2020年4月開始。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.